28 Jan 2020
Approved 505(b)(2) available for in-licensing:
CHP is pleased to announce the availability of an approved
505(b)(2) product in the cardiovascular space. US rights only.
has significant intellectual property rights. This product is ideally
suited for a company with a sales force calling on primary care providers and
Samples and inventory, supply and manufacturing agreements
are in place.
Return to Press Releases